Events

Inter Partes Reviews of Pharmaceutical Patents: Understanding How IPRs are Changing the Landscape of Innovator/Generic Litigation | IPO Webinar
- - UTC
Location

United States

Description

On Wednesday, July 23 at 2:00pm ET, Partner Mike Fuller will be a panelist on a webinar titled "Inter Partes Reviews of Pharmaceutical Patents: Understanding How IPRs are Changing the Landscape of Innovator/Generic Litigation." The webinar is hosted by IPO’s Pharmaceutical & Biotechnology Issues Committee.

This webinar will focus on the rapidly increasing use of IPRs to invalidate pharmaceutical patents in ANDA litigation. The webinar will first give an overview of the IPR process and timelines, and discuss the outcomes of recent IPR challenges in the pharmaceutical space, and then will focus on how generic firms are using IPRs to challenge innovator patents. With that background, our panel of experts will present tips and strategies for both challenging pharmaceutical patents and defending against such challenges.

Please join in for this informative and topical webinar and learn the latest information on how IPRs are changing the landscape of generic challenges to innovator patents.

Moderator: Paul Golian, Bristol-Myers Squibb Company

Speakers:

Aaron Barkoff, McAndrews, Held & Malloy, Ltd.

Grantland Drutchas, McDonnell Boehnen Hulbert & Berghoff LLP

Michael Fuller, Knobbe, Martens, Olson and Bear, LLP

No CLE credit available